Resources Contact Us Home
Humanized anti-CD70 binding agents and uses thereof

Image Number 17 for United States Patent #8067546.

Disclosed are CD70 binding agents, such as humanized anti-CD70 antibodies and fragments and derivatives, that exert a cytotoxic, cytostatic or immunomodulatory on CD70 expressing cells, as well as pharmaceutical compositions and kits comprising the antibody, fragment or derivative. Also disclosed are methods for the treatment of CD70-expressing cancers and immunological disorders, comprising administering to a subject the CD70 binding agents or pharmaceutical compositions.

  Recently Added Patents
Lubricant composition
Fast port switching in an audiovisual receiver by use of port pre-authentication by a partial PHY decoder core
Wireless refrigerant scale platform
Dynamic allocation of access channels based on access channel occupancy in a cellular wireless communication system
Method and apparatus for using virtual machine technology for managing parallel communicating applications
Method of fabricating solid electrolytic capacitor and solid electrolytic capacitor
Turbulence sensor and blade condition sensor system
  Randomly Featured Patents
Data processing system having a channel adapter shared by multiple operating systems
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a CLLD8 protein
Shower caddy
LED indicator retaining device
Extension element for use with wrench-type hand tools
Cam-guided adjustable pedal actuator assembly
Ski boat
Pen-type injector